Delivery Order SPE2DB20D9135-SPE2DB22FD2ZZ

Award Date 5/13/22
Potential Completion Date 6/6/22
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,584.16 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialty pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This federal contract award, with ID SPE2DB20D9329|SPE2DB24FZK19, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,737 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a pharmaceutical product, with a final completion date of May 16, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,612.88 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialty medication. The award is part of a larger $499,999,999 single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,653.12 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a pharmaceutical product, with a completion date of January 12, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,605.50 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, with an ultimate completion date of August 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This federal contract award, identified as SPE2DB20D9329|SPE2DB24FZJ67, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,284.40 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a pharmaceutical product, with a performance period ending on March 5, 2024. This award is issued under a larger indefinite delivery contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $79,354.56 firm fixed-price delivery order is for the provision of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialized biologic medication, to fulfill the recurring medical supply needs of military health facilities worldwide. The award is part of a larger $499,999,999 indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,677.28 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, with an ultimate completion date of January 25, 2022. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $46,531.20 firm fixed-price delivery order is for the supply of Xolair 150 mg/1.2 ml powder vials, with an ultimate completion date of October 13, 2021. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,642.20 contract is for the delivery of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialized pharmaceutical product, with a performance period through January 14, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB22FD2ZZ
    Delivery Order

This federal contract award, with ID SPE2DB20D9135|SPE2DB22FD2ZZ, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,959.66 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialized pharmaceutical product.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of the Department of Defense (DoD) healthcare facilities worldwide. DMS Pharmaceutical Group's position as a key supplier in the federal pharmaceutical supply chain is further bolstered by its separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites.

This particular delivery order does not have a set-aside designation, and the ultimate completion date is June 6, 2022.

Generated 1/9/25, 9:11 AM